Click on a filter below to refine your search. Remove a filter to broaden your search.
The findings were independent of chemotherapy-induced inflammation.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
The findings were seen among older adults in the six months following a COVID-19 hospitalization.
Detection rates appear to increase during nonacute office visits.